Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9040374 | 0.91 | AGTR1 (0.65) | AGTR1AGTR2 | |
| SCHEMBL8395661 | 0.91 | AGTR1 (0.65) | AGTR1AGTR2 | |
| SCHEMBL8392974 | 0.89 | AGTR1 (0.81) | AGTR1AGTR2 | |
| SCHEMBL8392429 | 0.88 | AGTR1 (0.80) | AGTR1AGTR2 | |
| SCHEMBL6567316 | 0.88 | AGTR1 (1.00) | AGTR1AGTR2 | |
| SCHEMBL8396147 | 0.88 | AGTR1 (0.79) | AGTR1AGTR2 | |
| SCHEMBL8396169 | 0.87 | AGTR1 (0.71) | AGTR1AGTR2 | |
| SCHEMBL9044303 | 0.87 | AGTR1 (0.60) | AGTR1AGTR2 | |
| SCHEMBL8944569 | 0.86 | AGTR1 (0.77) | AGTR1AGTR2 | |
| SCHEMBL8391160 | 0.86 | AGTR1 (0.86) | AGTR1AGTR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5864043-A | CARDIOVASCULAR DISORDERS AND ANGIOTENSIN ANTAGONIST | KARL THOMAE GMBH (DE) | 1999-01-26 | — | — | US | disclosed |
| US-5541229-A | ANGIOITENSIN II ANTAGONIST AS HYPOTENSIVE AGENTS, ANTIISCHEMIC AGENTS AND CARDIOVASCULAR DISORDERS | DR. KARL THOMAE GMBH (DE) | 1996-07-30 | — | — | US | disclosed |
| EP-0392317-B1 | Benzimidazoles, drugs containing these compounds and process for their preparation | THOMAE GMBH DR K (DE) | 1996-01-03 | — | — | EP | disclosed |
| EP-0392317-A2 | Benzimidazoles, drugs containing these compounds and process for their preparation | Dr. Karl Thomae GmbH (DE) | 1990-10-17 | — | — | EP | disclosed |